Clarivate helps you optimize each step of drug development – from discovery to commercialization – to bring treatments to market and patients faster.
Confidently prioritize and repurpose drugs and indications by combining Clarivate’s in-house customizable computational workflows with our proprietary databases (Cortellis Drug Discovery Intelligence, MetaBase molecular network database, OFF-X Translational Safety Intelligence) and expertise in bioinformatics, commercial assessment and knowledge curation.
We leverage approaches such as molecular network, pathway enrichment and disease similarity analyses, and integrate them using machine learning approaches to prioritize either targets to be repositioned, given indications of interest, or indications to be prioritized, given known targets.